Literature DB >> 11578322

CA 125 measurements in ovarian cancer patients during their first postoperative week.

O. Mogensen1, A. Brock, M. Holm Nyland.   

Abstract

Cancer antigen 125 (CA 125) was measured in 17 patients with ovarian carcinoma before their primary operation and during the first week after surgery. The purpose was to correlate the change in the antigen level with the patient's survival. Before surgery normal (16-30 U ml-1 CA 125 values were measured in four patients and 13 had increased (75-11.356 U ml-1) antigen concentrations. After surgery the marker increased to 104-931% of the preoperative level in five patients. In 12 patients the post-operative antigen level decreased to 20-96% of the preoperative level. In seven of these patients CA 125 increased without exceeding the preoperative level, after the initial postoperative fall. Thus, the CA 125 level during the first week after primary operation of ovarian cancer patients seems to be influenced by other variable factors besides a reduced amount of tumor tissue. Therefore, an investigation of the correlation between the change in the CA 125 concentration within the first week after surgery and the survival of the patient cannot be performed for the time being.

Entities:  

Year:  1993        PMID: 11578322     DOI: 10.1046/j.1525-1438.1993.03010054.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer.

Authors:  Seung-Chul Yoo; Jong-Hyuck Yoon; Mi-Ok Lyu; Woo Young Kim; Suk-Joon Chang; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

2.  Evaluation of leptin serum concentrations during surgery and first-line chemotherapy in primary epithelial ovarian cancer patients.

Authors:  Jacek Przemyslaw Grabowski; Anna Markowska; Janina Markowska
Journal:  Contemp Oncol (Pozn)       Date:  2014-11-05

3.  A Combinatorial Proteomic Biomarker Assay to Detect Ovarian Cancer in Women.

Authors:  Meredith C Henderson; Michael Silver; Sherri Borman; Quynh Tran; Elias Letsios; Rao Mulpuri; David E Reese; Judith K Wolf
Journal:  Biomark Cancer       Date:  2018-02-13

4.  Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?

Authors:  O Kiekegaard; O Mogensen; B Mogensen; S Ahrons
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.